ME
MediPharm Labs Corp.
MEDIF · OTC
$0.05 +0.00% (+$0.00)
1M -10.02%
Market Cap $30.7M
P/E Ratio -
Div. Yield -
ROE 13.79%
Bulios Fair Price
$0.07
37.3% upside
Current Price
$0.051
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MEDIF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.87x
P/S 0.74x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 13.87%
Rev. growth 26.80%
FCF growth N/A
Profitability
13 /100
Weak Net margin 11.99%
Op. margin 12.21%
FCF margin 2.22%
Quality
11 /100
Poor ROE 13.79%
ROA 10.81%
Asset turnover 0.90x
Debt
69 /100
Low Current ratio 2.69x
Int. coverage -80.62x
Debt/Equity 0.01x
Stability
62 /100
Moderate Rev. volatility 21.04%
EPS volatility 23.97%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MEDIF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Greg Hunter
Employees
127
Headquarters
Barrie
Upcoming events
12 NOV
Earnings
Upcoming earnings report